Pharmacists in Madill, OK Accepting Medicare
5 Pharmacists found. Showing 1 - 5
 Andrea Lynn Thompson Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1100 S 1st St, Madill, OK 73446 Phone: 580-795-3358 Fax: 580-795-2390 |
 Randall E Mcadoo, D.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 211 S 1st St, Madill, OK 73446 Phone: 580-795-7322 Fax: 580-795-2580 |
Lauren Rodriguez, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1100 S 1st St, Madill, OK 73446 Phone: 580-795-3358 |
Dr. Margaret Ann Perkins, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 E Main St, Madill, OK 73446 Phone: 580-795-3376 |
Guy Massey, DOCTOR OF PHARMACY Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1100 S 1st St, Madill, OK 73446 Phone: 580-795-3358 Fax: 580-795-2390 |
News Archive
Pharmasset, Bristol-Myers Squibb collaborate for proof of concept study on chronic HCV
Bristol-Myers Squibb Company and Pharmasset announced today that the companies have entered into a clinical collaboration agreement to evaluate the utility of BMS-790052, Bristol-Myers Squibb's NS5A replication complex inhibitor, in combination with PSI-7977, Pharmasset's nucleotide polymerase inhibitor, for the treatment of chronic hepatitis C virus.
New UK stem cell and regenerative medicine research centre
The new Wolfson Centre for Stem Cells, Tissue Engineering and Modelling (STEM) will be officially opened at the University of Nottingham on the 21st September, 2007 by Sir Keith O'Nions, Director General Science and Innovation at the Department for Innovation, Universities and Skills.
Frog skin proteins could treat cancer, diabetes and stroke: New discovery
Scientists at Queen's University Belfast have discovered proteins in frog skins which could be used to treat cancer, diabetes, stroke and transplant patients by regulating the growth of blood vessels.
Rebiotix's RBX2660 receives FDA Breakthrough Therapy designation for treatment of recurrent C diff infection
Rebiotix Inc. today announced that U.S. Food and Drug Administration has designated its lead Microbiota Restoration Therapy (MRT) RBX2660 as a Breakthrough Therapy for the treatment of recurrent Clostridium difficile (C diff) infection, a challenging to treat gastrointestinal (GI) infection that causes 29,000 deaths in the U.S. annually.
Researchers unravel genetic makeup of ticks to tackle disease
Ticks as small as a freckle can transmit a number of illnesses for which there is no vaccine and, in some cases, no cure. These creatures even could become bioterrorism weapons.
› Verified 6 days ago